Therapeutic properties: The “German Commission E” reports the use of Serenoa for the treatment of benign prostatic hypertrophy at stage I and II. Thanks to the action of fatty acids, titrated up to 30% in the supplement, Serenoa inhibits the enzyme 5alpha-reductase, responsible for converting testosterone into dihydrotestosterone. The latter, if in excess, is responsible for alopecia and prostate growth. The plant also reduces the link between the molecule and its receptor, thus mitigating the action of any dihydrotestosterone present. It has anti-inflammatory and relaxing action on muscles of urinary tract, relieving pain during diuresis. Some clinical studies have shown that Serenoa is as effective as finasteride in reducing the symptoms of benign prostatic hyperplasia (Capasso e coll., Fitoterapia. Impiego razionale delle piante medicinali, 2006).

For preventiona nd control of: UROGENITAL DISORDERS